OGT to share expertise in NGS assay design through live webinar presentation

Live webinar will focus on enhanced bait design 

Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, will share its expertise in NGS assay design by hosting a live webinar entitled ‘Enhanced bait design strategies that deliver more reliable NGS panel assays’ on 3rd October 2013, at 3:00pm (BST).

Guest speaker, Dr Chris Mattocks, Senior Clinical Research Scientist at the National Genetics Reference Laboratory (Wessex), Salisbury UK, will discuss the advantages of hybridisation enrichment and the importance of optimal bait design to ensure increased uniformity for all target regions. 

As the use of NGS moves closer to the clinic, it is of paramount importance that relevant mutations can be detected and called with complete certainty. Only reliable and reproducible methods will inspire enough confidence to allow the transition of NGS assays from useful research tools to clinically dependable tests. 

As such, it is becoming increasingly apparent that some NGS enrichment methods do not reliably detect known mutants due to issues with PCR artefacts, excessive off-target enrichment, target region bias, non-uniformity of coverage or even wholesale target region drop-out. This highlights the need for methods with increased uniformity of coverage (when each locus is read at sufficient depth without resorting to increasing the number of reads) and minimal variation between loci, to provide confidence that all loci are covered at dependable levels.

As well as discussing bait design, the webinar will also cover the impact of coverage, non-conformity on sequencing efficiency and cost, and how coverage affects confidence levels in the results.

OGT’s significant expertise in NGS is demonstrated by Genefficiency™ Custom Targeted Sequencing Services, which combine expert bait design with a unique and fully interactive variant analysis report that delivers rapid access to reliable, meaningful results.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Gene Technology. (2019, June 19). OGT to share expertise in NGS assay design through live webinar presentation. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20130919/OGT-to-share-expertise-in-NGS-assay-design-through-live-webinar-presentation.aspx.

  • MLA

    Oxford Gene Technology. "OGT to share expertise in NGS assay design through live webinar presentation". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20130919/OGT-to-share-expertise-in-NGS-assay-design-through-live-webinar-presentation.aspx>.

  • Chicago

    Oxford Gene Technology. "OGT to share expertise in NGS assay design through live webinar presentation". News-Medical. https://www.news-medical.net/news/20130919/OGT-to-share-expertise-in-NGS-assay-design-through-live-webinar-presentation.aspx. (accessed December 22, 2024).

  • Harvard

    Oxford Gene Technology. 2019. OGT to share expertise in NGS assay design through live webinar presentation. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20130919/OGT-to-share-expertise-in-NGS-assay-design-through-live-webinar-presentation.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
OGT increases NGS cancer panel content to provide more flexibility for customization